Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
Open accessThe DOI matches its Crossref record; 131 of the 133 references it cites were found in a registry or an index.
Abstract
Oxidative cellular damage caused by free radicals is known to contribute to the pathogenesis of various diseases such as cancer, diabetes, and neurodegenerative diseases, as well as to aging. The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein1 (Keap1) signaling pathways play an important role in preventing stresses including oxidative and inflammatory stresses. Nrf2 is a master regulator of cellular stress responses, induces the expression of antioxidant and detoxification enzymes, and protects against oxidative stress-induced cell damage. Glucagon-like peptide-1 (GLP-1) is an incretin hormone, which was originally found to increase insulin synthesis and secretion. It is now widely accepted that GLP-1 has multiple functions beyond glucose control in various tissues and organs including brain, kidney, and heart. GLP-1 and GLP-1 receptor agonists are known to be effective in many chronic diseases, including diabetes, via antioxidative mechanisms. In this review, we summarize the current knowledge regarding the role of GLP-1 in the protection against oxidative damage and the activation of the Nrf2 signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“dysfunction of endothelial cells, induced by hyperglycemia and driven by this systemic proinflammatory state, trigger cardiomyocyte dysfunction in HFpEF.”
From The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF (2023) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The Nrf2 signaling pathway, a master regulator of cellular antioxidant defense mechanisms, is upregulated by GLP-1 receptor activation, according to preclinical research (49).”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Improvements in HF-related symptoms and physical function have been broadly recognized as key goals of care in patients with HFpEF by clinicians, professional societies and regulators. 45”
From Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials (2024) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 2×
“In addition to its actions on the pancreas, GLP-1 reduces glucose production in the liver and increases glucose uptake in adipose tissue and muscle [64,78,79].”
BackgroundCell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630 · cited 2×
“Under basic conditions, Nrf2 is bound to the endogenous inhibitor Kelch-like ECH-associated protein1 (Keap1), which is anchored to actin in the cytoskeleton in the cytosol, and suppressed by Keap1-dependent ubiquitination-proteasomal degradation [8].”
BackgroundThe biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210 · cited 1×
“GLP-1 has many additional effects; it delays gastric emptying, inhibits food intake, improves insulin sensitivity, inhibits glucagon secretion, and stimulates insulin biosynthesis [18,53].”
BackgroundThe Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova-Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,141 · cited 2×
“Nrf2–ARE binding regulates the expression of genes involved in cellular antioxidant and anti-inflammatory responses such as superoxide dismutase, catalase, glutathione peroxidases, thioredoxin, thioredoxin reductase, sulfiredoxin, NADPH:quinone oxidoreductase-1, heme oxygenase-1, glutathione reductase, glutaredoxin, g…”
BackgroundAntioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species
He, L., He, T., Farrar, S., Ji, L., Liu, T., & Ma, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485089 · Cited by 2,127
Cellular mechanisms and physiological consequences of redox-dependent signalling
Holmström, K. M., & Finkel, T. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3801 · Cited by 2,093
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Strategies of antioxidant defense
SIES, H. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18025.x · Cited by 1,976
Cited by
Items 201–217 of 217
Chen, Y., Chang, C., Chen, L., Huang, C., Yu, C., Lin, V. C., Lu, T., Huang, S., & Bao, B. (2025) · Diagnostics · doi:10.3390/diagnostics15212767
Findling, E., Bissoondial, T., & Prakash Narayan, A. (2026) · Cureus · doi:10.7759/cureus.106280
“In addition, GLP-1 signaling has been shown to suppress inflammatory cytokine production and oxidative stress, both of which are key drivers of stellate cell activation [29].”
Génération contrôlée et détermination de l'impact toxicologique des aérosols organiques secondaires
Jacob, F. (2023) · theses.fr (ABES) · doi:10.70675/9b2cd0d6ze483z4f11zb21bzef8cf81b5ba1 · Cited by 1
Li, J., Li, C., Yang, C., Zhu, Z., Ran, H., Liu, B., Zhang, Y., & Xiang, Y. (2026) · Peptides · doi:10.1016/j.peptides.2026.171489
Semaglutide and Its Potential Hepatoprotective Effects Against Acute Drug-Induced Liver Injury
Charatsi, E., Liberopoulos, E. N., Pergialiotis, V., Kontzoglou, K., Kykalos, S., & Iliopoulos, D. (2026) · Cureus · doi:10.7759/cureus.107715
GLP-1R R131Q links long-range conformational remodeling to cellular stress phenotypes
Kato, T., Inomata, N., Serizawa, K., Matsuo, Y., Oguchi, M., Kuranami, S., Sakurai, Y., Aoyama, T., Ken, S., Shojima, N., et al. (2026) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2026.109445
Nrf2 signaling pathway and its molecular regulatory mechanism
Pan, Y., Zhang, X., Lu, Y., Qin, H., Chen, R., & Fan, H. (2026) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2500053 · Cited by 1
“This orchestrated response confers cellular protection against oxidative insult mediated by reactive oxygen species (ROS) and ionizing radiation (Oh and Jun, 2018; Huang et al., 2023).”
Karakullukçu, H. K., Gül, S. Ş., Aygün, H., Kalın, M., Karakullukcu, M., Arslan, A., Özkan, Ö. F., & Ercan, G. (2026) · Pharmaceuticals · doi:10.3390/ph19071086
“Exenatide partially corrected these abnormalities, consistent with previous studies showing that GLP-1 receptor agonists reduce oxidative burden and improve antioxidant defenses, partly through mechanisms associated with Nrf2 signaling and mitochondrial stress adaptation [13,20].”
Maher, O. W., El-Sayed, N. M., El‐Awady, E., El-Orabi, N. F., & Radwan, A. (2026) · Biomedicines · doi:10.3390/biomedicines14081714
“MTX increases TNF-α [56], and IL-4 Levels [57], which are key pro-inflammatory cytokines involved in promoting inflammatory responses and enhancing oxidative stress via nitric oxide (NO) and other mediators [58].”
Zimmerman, E. A., & Shirani, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-13040-2_3
Serendipitous Discovery of Short Peptides Dimethylammonium Salt Promoting Neural Differentiation
Khan, S. N., Shahid, M., Nazir, S., Bashir, A., Sheikh, S., Sımjee, S. U., Maresca, M., & Shaheen, F. (2026) · Journal of Peptide Science · doi:10.1002/psc.70124
Tang, B., Yu, Y., Tang, Y., Yu, R., & Liu, X. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-121200
Ojo, P. O., Rotimi, D. E., Ezenabor, E. H., Akanji, M. A., & Adeyemı, O. S. (2026) · Discover Medicine · doi:10.1007/s44337-026-00686-6
Pascalis, A. D., Vetrano, D., Tomassetti, A., Barbuto, S., Nunzio, M. D., Foà, A., Potena, L., Barbuto, S., & Cianciolo, G. (2026) · Kidney Medicine · doi:10.1016/j.xkme.2026.101553
GLP-1 receptor agonists—a potential therapy for chronic kidney disease?
Boeckhaus, J., Sayer, J. A., & Mabillard, H. R. (2026) · Clinical Science · doi:10.1042/cs20261312
Interplay Between the Gut Microbiome and Oxidative Stress in Type 2 Diabetes
Kim, J.-W., Lee, Y., Kim, K., & Ko, S.-H. (2026) · Antioxidants · doi:10.3390/antiox15101278
“However, it is difficult to determine how much is a direct receptor effect versus a consequence of weight loss and improved glycemia [103–105].”
GLP-1 as a Regulator of Oxidative Signalling in Metabolic Health and Disease
Kurhaluk, N., Kołodziejska, R., & Ткаченко, Г. М. (2026) · Antioxidants · doi:10.3390/antiox15101283 · Cited by 1
Metadata
- Authors
- Oh, Y., & Jun, H.-S.
- Affiliations
- Eulji University (KR)
- Gachon University (KR)
- Corresponding author
- Jun, Hee-Sook
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-12-22
- Volume
- 19
- Issue
- 1
- Pages
- 26
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5795977
- OpenAlex
- W2779001901
- Semantic Scholar
- 8fd8d98ecad3afa2039a39b8a6478a9494f9a746
- Cited by
- 217
- References
- 133
- Citations by year
- 2026: 24 · 2025: 50 · 2024: 41 · 2023: 19 · 2022: 21 · 2021: 31 · 2020: 12 · 2019: 9 · 2018: 9 · 2017: 1
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- Korea Health Industry Development Institute (HI15C0987)
- National Research Foundation of Korea (NRF-2015R1D1A1A01058888)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucagon-like peptide-1, Nrf2 signaling, Keap1, oxidative stress, antioxidant defense, incretins, GLP-1 receptor agonists, free radicals, cellular stress response, diabetes mellitus
- MeSH terms
- Animals, Diabetes Mellitus, Humans, Nervous System Diseases, Signal Transduction, Reactive Oxygen Species, Oxidative Stress, NF-E2-Related Factor 2, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.